- Report
- August 2025
- 138 Pages
Global
From €3510EUR$3,999USD£3,054GBP
- Report
- March 2025
- 144 Pages
Global
From €3510EUR$3,999USD£3,054GBP
- Report
- April 2025
- 175 Pages
Global
From €5223EUR$5,950USD£4,544GBP
- Report
- February 2026
- 374 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 177 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 372 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- October 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- March 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- February 2026
- 162 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 192 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 273 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- January 2026
- 190 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 185 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 197 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 180 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 198 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 197 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 193 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 184 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 191 Pages
Global
From €3458EUR$3,939USD£3,008GBP

Retinopathy is a medical condition that affects the retina, the light-sensitive tissue at the back of the eye. It is a leading cause of blindness and visual impairment worldwide. Optical treatments for retinopathy include laser photocoagulation, intravitreal injections, and vitrectomy. Laser photocoagulation is used to reduce the risk of vision loss by sealing off leaking blood vessels in the retina. Intravitreal injections are used to deliver medications directly to the retina to reduce swelling and inflammation. Vitrectomy is a surgical procedure used to remove scar tissue and other debris from the vitreous cavity.
Companies in the retinopathy market include Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Heidelberg Engineering, Nidek, Optos, Topcon, and Zeiss. Show Less Read more